Department of Internal Medicine, Busan Paik Hospital, Inje University, Busan, Korea.
Int J Immunogenet. 2013 Dec;40(6):502-8. doi: 10.1111/iji.12069. Epub 2013 Jun 13.
The Toll-like receptors (TLRs) are related to innate immunity. TLR9, a member of TLRs, is expressed in immune cell-rich tissues and mediates cellular response. We investigated the association between TLR9 polymorphisms and kidney allograft outcomes. To investigate whether TLR9 polymorphisms are associated with acute rejection after renal transplantation, two single nucleotide polymorphisms (SNPs) of TLR9 gene (rs187084 -1486; rs352140, G2848A) were selected and genotyped by direct sequencing in 342 renal transplant recipients. SNPStats, SNPAnalyzer, Helixtree and Haploview version 4.2 were used to analyse genetic data. Multiple logistic regression models (codominant, dominant, recessive and log-additive) were used to evaluate odds ratios (ORs), 95% confidence intervals (CIs) and P values. Both SNPs, TLR9 rs187084 -1486 and rs352140 G2848A, of recipients were associated with the risk of acute rejection in renal transplantation. C allele of rs187084 -1486 and A allele of rs352140 G2848A were protective genotype for acute rejection (OR 0.6, 95% CI 0.40-0.92; P = 0.018, OR 0.64, 95% CI 0.42-0.98; P = 0.04, respectively). rs187084 -1486 CT and rs352140 G2848A GA genotype were associated with a lower eGFR after a year of renal transplantation. TLR9 polymorphisms, rs187084 and rs352140, of recipients were associated with the risk of acute rejection in renal transplantation. The patients with rs187084 -1486 CT and rs352140 G2848A GA genotype showed a lower eGFR after a year of renal transplantation.
Toll 样受体 (TLRs) 与先天免疫有关。TLR9 是 TLRs 的一个成员,在富含免疫细胞的组织中表达,并介导细胞反应。我们研究了 TLR9 多态性与肾移植结局的关系。为了研究 TLR9 多态性是否与肾移植后急性排斥反应有关,我们选择了 TLR9 基因的两个单核苷酸多态性 (SNP) (rs187084-1486; rs352140,G2848A),并通过直接测序在 342 名肾移植受者中进行了基因分型。使用 SNPStats、SNPAnalyzer、Helixtree 和 Haploview 版本 4.2 分析遗传数据。多因素逻辑回归模型 (共显性、显性、隐性和对数相加) 用于评估比值比 (OR)、95%置信区间 (CI) 和 P 值。TLR9 rs187084-1486 和 rs352140 G2848A 的受体均与肾移植中急性排斥反应的风险相关。rs187084-1486 的 C 等位基因和 rs352140 G2848A 的 A 等位基因是急性排斥反应的保护基因型(OR 0.6,95%CI 0.40-0.92;P=0.018,OR 0.64,95%CI 0.42-0.98;P=0.04)。rs187084-1486 CT 和 rs352140 G2848A GA 基因型与肾移植后 1 年的 eGFR 降低有关。TLR9 受体多态性 rs187084 和 rs352140 与肾移植中急性排斥反应的风险相关。rs187084-1486 CT 和 rs352140 G2848A GA 基因型的患者在肾移植后 1 年的 eGFR 较低。